Division of Metabolic & Endocrine Products director
Executive Summary
Acting Division of Metabolic & Endocrine Products Director Mary Parks will hold the permanent position as of Aug. 6. Parks, former ODE II division deputy director and team leader for lipid-lowering drugs, was promoted to director following the departure of David Orloff Jan. 1 (1The Pink Sheet" Dec. 12, 2005, In Brief)...